Partner Headlines - THRX

  1. Drug M&A Boom Driven By Long-Term Trends: PwC

    IBD
  2. Barron's Recap: Ready To Wear?

    Benzinga
  3. UPDATE: Bank Of America Downgrades Theravance As Pricing Headwinds ...

    Benzinga
  4. UPDATE: Morgan Stanley Reiterates On Theravance As Slow Trends ...

    Benzinga
  5. Theravance, Inc. Appoints Theodore J. Witek, Jr. As Senior VP, ...

    Benzinga
  6. UPDATE: Stifel Downgrades Theravance Following Post-Split Accretion

    Benzinga
  7. Benzinga's Top Downgrades

    Benzinga
  8. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies ...

    Benzinga
  9. Theravance Announces Positive Results From a Phase 2 Study of ...

    Benzinga
  10. Theravance Announces Initiation of Phase 2b Study With TD-42 ...

    Benzinga
  11. Glaxo's COPD Drug Gets European Green Light

    FoxBusiness
  12. Morgan Stanley Expects Theravance to Continue to Underperform ...

    Benzinga
  13. Top 2013 Drug Approvals: Pharma Stocks

    YCharts
  14. Positive data for asthma drug

    IBD
  15. Theravance, Glaxo COPD Drug Does Well In Asthma

    IBD
  16. Seth Klarman Buys Micron Technology, Theravance, PBF Energy, ...

    GuruFocus
  17. GlaxoSmithKline

    IBD
  18. US Stock Futures Signal Flat Start On Wall Street

    Benzinga
  19. Relvar Ellipta Approved in Japan for Treatment of Asthma

    Benzinga
  20. Glaxo, Theravance Confirm Positive CHMP Opinion for Relvar Ellipta

    Benzinga
  21. Glaxo, Theravance Confirms FDA Panel Has Recommended Approval ...

    Benzinga
  22. Theravance Reports Results from Phase 2B Study 0091 with TD-42 ...

    Benzinga
  23. Missed Klarman’s 47% Gainer? His Other Value Pick

    YCharts
  24. Seth Klarman's Top 5 Second Quarter Holdings

    GuruFocus
  25. Perrigo-Elan Merger Creates Unlikely Pharma Union

    IBD
  26. UPDATE: Stifel Nicolaus Cuts PT to $37 on Theravance Ahead of ...

    Benzinga
  27. Theravance to Offer $250 Million Convertible Subordinated Notes ...

    Benzinga
  28. Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN

    GuruFocus
  29. Theravance Confirms Favorable Ruling from FDA Panel on VIBATIV

    Benzinga
  30. Theravance Offers FDA Briefing Documents for Panel Meeting on ...

    Benzinga
  31. Theravance Enters Agreement With Alfa Wassermann Worth Up To ...

    Benzinga
  32. The Baupost Group's Favorite Stocks

    Benzinga
  33. Theravance Inc. (THRX) Sr VP, CFO Michael W Aguiar sells 24,682 ...

    GuruFocus
  34. GSK and Theravance Announce Completion of the Phase III Programme ...

    Benzinga
  35. Weekly CFO Sells Highlight: SWN, BECN, NSIT, HOLX, QLTI, THRX

    GuruFocus
  36. Theravance Inc. (THRX) Sr VP, CFO Michael W Aguiar sells 60, ...

    GuruFocus
  37. Theravance Inc. (THRX) CEO Rick E Winningham sells 75,749 Shares

    GuruFocus
  38. A Peek Into The Market Before The Trading Starts

    Benzinga
  39. GSK and Theravance Announce Regulatory Submissions for FF/VI ...

    Benzinga
  40. Target, Amgen Among Stocks Hitting 52-Week Highs Wednesday

    FoxBusiness
  41. Dendreon, Pharmacyclics and Other Biotech Takeover Targets

    Benzinga
  42. Merck &, Questcor Pharmaceuticals, Other Stocks Hit 52-Week Highs ...

    FoxBusiness
  43. Health Care Sector Wrap

    FoxBusiness
  44. Health Care Sector Wrap

    FoxBusiness
  45. GSK and Theravance Announce Positive Results From Four Pivotal ...

    Benzinga
  46. Theravance Inc. Reports Operating Results (10-K)

    GuruFocus
  47. UPDATE: Morgan Stanley Initiates Underweight, $12 PT on Theravance

    Benzinga
  48. Morgan Stanley Initiates Theravance at Underweight

    Benzinga
  49. Afternoon Movers; Markets Moved Higher

    Benzinga
  50. Morning Market Losers

    Benzinga
  51. From Earlier: GSK and Theravance Announce Initial Outcomes From ...

    Benzinga
  52. UPDATE: Piper Jaffray Raises Price Target on Theravance to $35

    Benzinga
  53. Piper Jaffray Raises PT on Theravance to $35

    Benzinga
  54. Notable Put Options Activity in Theravance

    Benzinga
  55. Theravance Inc. (THRX) Sr VP, CFO Michael W Aguiar sells 10, ...

    GuruFocus
Trading Center